Matches in Wikidata for { <http://www.wikidata.org/entity/Q108592050> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- Q108592050 description "2020 ވަނަ އަހަރު ޝާއިޢުކުރެވިފައިވާ ޢިލްމީ ލިޔުމެއް" @default.
- Q108592050 description "article científic" @default.
- Q108592050 description "article scientifique" @default.
- Q108592050 description "articol științific" @default.
- Q108592050 description "articolo scientifico" @default.
- Q108592050 description "artigo científico" @default.
- Q108592050 description "artigo científico" @default.
- Q108592050 description "artigo científico" @default.
- Q108592050 description "artikel ilmiah" @default.
- Q108592050 description "artikull shkencor" @default.
- Q108592050 description "artículo científico" @default.
- Q108592050 description "artículu científicu" @default.
- Q108592050 description "bilimsel makale" @default.
- Q108592050 description "journal article from 'International Journal of Molecular Sciences' published in 2021" @default.
- Q108592050 description "maqolai ilmiy" @default.
- Q108592050 description "scienca artikolo" @default.
- Q108592050 description "vedecký článok" @default.
- Q108592050 description "vetenskaplig artikel" @default.
- Q108592050 description "vitenskapelig artikkel" @default.
- Q108592050 description "vitskapeleg artikkel" @default.
- Q108592050 description "vědecký článek" @default.
- Q108592050 description "wetenschappelijk artikel" @default.
- Q108592050 description "wissenschaftlicher Artikel" @default.
- Q108592050 description "мақолаи илмӣ" @default.
- Q108592050 description "наукова стаття" @default.
- Q108592050 description "научная статья" @default.
- Q108592050 description "научни чланак" @default.
- Q108592050 description "מאמר מדעי" @default.
- Q108592050 description "مقالة علمية" @default.
- Q108592050 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q108592050 name "Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models" @default.
- Q108592050 name "Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models" @default.
- Q108592050 type Item @default.
- Q108592050 label "Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models" @default.
- Q108592050 label "Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models" @default.
- Q108592050 prefLabel "Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models" @default.
- Q108592050 prefLabel "Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models" @default.
- Q108592050 P1433 Q108592050-801585EF-6111-48CB-9D2B-E9B9FAAFB0F0 @default.
- Q108592050 P1476 Q108592050-6DCBFFDF-24B8-437F-BF2C-35B57D71CF8C @default.
- Q108592050 P2093 Q108592050-5D3C07A2-B2EE-47DF-93DA-5180F72D72CE @default.
- Q108592050 P2093 Q108592050-5DD2143E-3A2E-4882-A823-EB06521E3754 @default.
- Q108592050 P2093 Q108592050-62513235-00A0-48F0-980A-238288AA93C0 @default.
- Q108592050 P2093 Q108592050-66336A54-8DA8-438F-AF83-8DF985870F44 @default.
- Q108592050 P2093 Q108592050-82F6F91A-A551-4B22-92AD-16ECE8511D5D @default.
- Q108592050 P2093 Q108592050-9E2A37DC-14DF-4FDE-9DFB-9FE2BADDC545 @default.
- Q108592050 P2093 Q108592050-CAB71D3D-F4A5-4444-B722-C562F2C32E3F @default.
- Q108592050 P2093 Q108592050-D3A48CDB-7DAC-468B-98E3-D973256485B1 @default.
- Q108592050 P275 Q108592050-b4e61a64-f26f-4066-bd16-b3ff6e003026 @default.
- Q108592050 P304 Q108592050-E070BDD6-EEC3-4FE7-BCCC-8EED211CEAE9 @default.
- Q108592050 P31 Q108592050-655108B9-9EAF-4763-8EBB-E05CA2BD2216 @default.
- Q108592050 P356 Q108592050-01CEE147-8788-4F1B-A8FD-2F9C4FE63C5C @default.
- Q108592050 P407 Q108592050-4E6D59E4-A632-4339-BAA7-04B69BBB8B10 @default.
- Q108592050 P433 Q108592050-CDA30923-2433-4E19-9B43-8E4F1C09BAA3 @default.
- Q108592050 P478 Q108592050-EDD17B40-9EFC-478B-B09F-BDE4E236C8B7 @default.
- Q108592050 P577 Q108592050-99C18093-C066-450A-A454-EF2260F93118 @default.
- Q108592050 P6216 Q108592050-4e7eb69c-6c14-41bc-81a8-f57cfa2c6493 @default.
- Q108592050 P921 Q108592050-6FFDA573-1AE3-4BE5-9ADD-826838A56FE3 @default.
- Q108592050 P953 Q108592050-B59493BA-53AD-4C6E-A922-6A6923EFB6E4 @default.
- Q108592050 P356 IJMS22020536 @default.
- Q108592050 P1433 Q3153277 @default.
- Q108592050 P1476 "Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models" @default.
- Q108592050 P2093 "Cheong Soo Park" @default.
- Q108592050 P2093 "Hang-Seok Chang" @default.
- Q108592050 P2093 "Hee Jun Kim" @default.
- Q108592050 P2093 "Ho-Jin Chang" @default.
- Q108592050 P2093 "Hyeok Jun Yun" @default.
- Q108592050 P2093 "Jungmin Kim" @default.
- Q108592050 P2093 "Ki Cheong Park" @default.
- Q108592050 P2093 "Sang Yong Kim" @default.
- Q108592050 P275 Q20007257 @default.
- Q108592050 P304 "536" @default.
- Q108592050 P31 Q13442814 @default.
- Q108592050 P356 "10.3390/IJMS22020536" @default.
- Q108592050 P407 Q1860 @default.
- Q108592050 P433 "2" @default.
- Q108592050 P478 "22" @default.
- Q108592050 P577 "2021-01-01T00:00:00Z" @default.
- Q108592050 P6216 Q50423863 @default.
- Q108592050 P921 Q3658382 @default.
- Q108592050 P953 536 @default.